Genexine, Foreign Investors Net Sell 25,000 Shares... Stock Price -0.1%

Genexine has ranked among the top searched stocks for 4 days in the past month.

As of 12:31 PM on the 24th, Genexine is trading at 100,400 KRW, down 0.1% from the previous day. This represents a 34.58% increase compared to June 3. Genexine is known as a specialized company in biopharmaceutical development.

Today, foreigners have tentatively sold a net 25,000 shares of Genexine, while institutions have bought a net 2,000 shares. Over the past 5 days, individual investors have bought a net 759,948 shares, whereas foreigners and institutions have sold a net 92,893 shares and 99,250 shares respectively.

On June 19, Genexine became a market issue with the news of the "first domestic" COVID-19 vaccine administered to humans, causing a "sharp rise."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.